close
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu

The RIQAS BNP EQA programme is a dedicated programme suitable for use monitoring the performance of B-type Natriuretic Peptide.

Liquid ready-to-use samples requiring minimal preparation

Submit results and view reports online via RIQAS.Net

World's largest EQA scheme ensures peer groups are maximised

Monthly reporting to reduce the risk of errors

Cycle Starts - January 2026

Accredited to ISO17043:2023 standard via RIQAS flexible scope

Get in touch to discover more

To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.

DescriptionFrequencySizeCat No
BNPMonthly12 x 1 mlRQ9165

Parameter

  • BNP

Please note, product availability may vary country to country.

Related RIQAS EQA Programmes

Cardiac

Cardiac Plus

General Clinical Chemistry

Acusera QC
Complete QC Solutions for Results you Can Trust
RIQAS Brochure
Randox International Quality Assessment Scheme
QCMD
QCMD EQA/PT Schemes for Molecular Infectious Disease Testing.